The Institute of Addiction Medicine (IAM) was formed to address an important need in Addiction Treatment, namely to bring evidence based treatments into clinical practice. IAM seeks to enhance the understanding and treatment of alcohol addiction and addiction to other substances and maladaptive behaviors such as overeating and gambling.

In the US, there are over 18 million people suffering from an Alcohol Use Disorder (AUD). Of those, only 2 million receive treatment and less than 10% recieve medication of any kind even though Naltrexone was FDA approved back in 1994. Since then, two other medications have been approved for treatment as well and countless of research has been done to show the effectiveness of the meds. Still treatment centers are not taking full advantage of these options, but...

That is all about to change... that's our mission.

The Institute of Addiction Medicine is pleased to announce the appointment of Joseph R. Volpicelli, M.D., Ph.D. as CEO and President. Dr. Volpicelli has facilitated the establishment of clinical treatment programs consistent with evidence based treatments. IAM is dedicated to finding novel evidence based treatments through clinical research and the dissemination of this research through scientific publications and conferences.